Page last updated: 2024-10-22

albuterol and Strongyloidiasis

albuterol has been researched along with Strongyloidiasis in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Strongyloidiasis: Infection with nematodes of the genus STRONGYLOIDES. The presence of larvae may produce pneumonitis and the presence of adult worms in the intestine could lead to moderate to severe diarrhea.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ferreira, CM1
Pereira, AT1
de Souza, RS1
Cassali, GD1
Souza, DG1
Lemos, VS1
Teixeira, MM1
Negrão-Corrêa, D1

Other Studies

1 other study available for albuterol and Strongyloidiasis

ArticleYear
Prevention of changes in airway function facilitates Strongyloides venezuelensis infection in rats.
    Microbes and infection, 2007, Volume: 9, Issue:7

    Topics: Acetylcholine; Albuterol; Animals; Bronchial Hyperreactivity; Bronchodilator Agents; Eosinophilia; G

2007